theory clinical_106_5
imports Main

begin

typedecl entity
typedecl event

consts
  HER2V777L :: "entity ⇒ bool"
  HER2Amplification :: "entity ⇒ bool"
  BreastCancer :: "entity ⇒ bool"
  Coincident :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Resistance :: "entity ⇒ bool"
  Trastuzumab :: "entity ⇒ bool"
  Develop :: "event ⇒ bool"
  AntibodyTherapies :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Mechanism :: "entity ⇒ bool"
  PrimaryFactor :: "entity ⇒ bool"
  Lead :: "event ⇒ bool"
  Direct :: "entity ⇒ bool"
  Involving :: "event ⇒ bool"
  Occur :: "event ⇒ bool"
  TrastuzumabTherapy :: "entity ⇒ bool"
  AntibodyTherapy :: "entity ⇒ bool"

(* Explanation 1: HER2 V777L is coincident with HER2-amplification in breast cancers that have developed resistance to Trastuzumab. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. HER2V777L x ∧ HER2Amplification y ∧ BreastCancer z ∧ Coincident e1 ∧ Agent e1 x ∧ Patient e1 y ∧ In y z ∧ Resistance z ∧ Trastuzumab z ∧ Develop e2 ∧ Agent e2 z"

(* Explanation 2: HER2 V777L can directly cause resistance to antibody therapies, including Trastuzumab, by being a primary factor in mechanisms that lead to such resistance. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. HER2V777L x ∧ Resistance y ∧ AntibodyTherapies y ∧ Trastuzumab y ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Mechanism z ∧ PrimaryFactor z ∧ Lead e2 ∧ Agent e2 z ∧ Patient e2 y"

(* Explanation 3: This patient may develop resistance to Trastuzumab therapy due to direct mechanisms involving HER2 V777L. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. Resistance y ∧ TrastuzumabTherapy y ∧ Develop e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Mechanism z ∧ Direct z ∧ Involving e2 ∧ Agent e2 z ∧ Patient e2 x ∧ HER2V777L x"

(* Explanation 4: Resistance to antibody therapies, including Trastuzumab, can occur due to mechanisms involving HER2 V777L. *)
axiomatization where
  explanation_4: "∃x y z e1. Resistance x ∧ AntibodyTherapies x ∧ Trastuzumab x ∧ Occur e1 ∧ Agent e1 x ∧ Mechanism y ∧ Involving e1 ∧ Agent e1 y ∧ Patient e1 x ∧ HER2V777L y"

theorem hypothesis:
  assumes asm: "HER2V777L x ∧ Resistance y ∧ AntibodyTherapy y"
  (* Hypothesis: HER2 V777L may cause resistance to antibody therapy *)
  shows "∃x y e. HER2V777L x ∧ Resistance y ∧ AntibodyTherapy y ∧ Cause e ∧ Agent e x ∧ Patient e y"
proof -
  (* From the premise, we have the known information about HER2 V777L, resistance, and antibody therapy. *)
  from asm have "HER2V777L x ∧ Resistance y ∧ AntibodyTherapy y" by simp
  (* Explanation 2 states that HER2 V777L can directly cause resistance to antibody therapies, including Trastuzumab. *)
  (* This aligns with the logical proposition C. *)
  (* We have a logical relation Implies(C, D), which implies that mechanisms involving HER2 V777L lead to resistance to antibody therapies. *)
  (* From explanation 2, we can infer the existence of a cause event. *)
  then have "∃e. Cause e ∧ Agent e x ∧ Patient e y" sledgehammer
  (* Combining the known information and the inferred cause event, we can conclude the hypothesis. *)
  then show ?thesis <ATP>
qed

end
